Whistleblower News: Radeas LLC Agrees To Pay $11.6M To Resolve Allegations Of Fraudulent Billing, False Claims Act Suit Against General Medicine P.C. And Related Entities For Medicare Fraud, Closing Arguments Begin In Ex-Goldman Banker's 1MDB Trial
Radeas LLC Agrees to Pay $11.6 Million to Resolve Allegations of Fraudulent Billing
DOJ
A North Carolina-based clinical laboratory, Radeas LLC, has agreed to pay $11.6 million to resolve allegations that it submitted false claims for payment to Medicare for medically unnecessary urine drug testing (UDT). read more »
United States Files False Claims Act Suit Against General Medicine, P.C. and Related Entities for Medicare Fraud
DOJ
The United States filed suit in U.S. District Court for the Southern District of Illinois against General Medicine, P.C. (“General Medicine”), Thomas M. Prose, M.D. – the owner of General Medicine, and seventeen related corporate entities owned by Prose. In a 96-page complaint, the government alleges Defendants violated the False Claims Act in a widespread healthcare fraud scheme involving the submission of thousands of false claims to the Medicare program. Since 2016, Medicare has paid defendants over $40 million dollars. read more »
Closing arguments begin in ex-Goldman banker's 1MDB corruption trial
REUTERS
Closing arguments began on Monday in the U.S. trial of a former Goldman Sachs (GS.N) banker accused of helping loot Malaysia's 1MDB development fund, with a U.S. prosecutor urging jurors not to discount testimony from the government's star witness because he was seeking leniency. read more »